UK and EU Food Supplement Compliance: Regulatory Baselines for Brand Owners

Navigating the regulatory landscape for food supplements across the United Kingdom and the European Union requires rigorous adherence to food safety legislation, compositional thresholds, and statutory labelling requirements. For brand owners, contract manufacturers, and formulators, maintaining technical compliance is essential to ensure consumer safety, satisfy local enforcement authorities, and mitigate the risk of product recalls or import detentions. Following the UK's withdrawal from the EU, regulatory pathways have diverged between Great Britain (England, Scotland, and Wales) and EU Member States, while Northern Ireland remains aligned with the EU internal market rules under the Windsor Framework. Despite procedural divergence, safety benchmarks and scientific baselines remain closely aligned across the UK Food Standards Agency (FSA), Food Standards Scotland (FSS), and the European Food Safety Authority (EFSA). ## Statutory Baselines and Food Business Operator Duties In both jurisdictions, food supplements are defined under Directive 2002/46/EC (and its transposed national equivalents, such as the Food Supplements (England) Regulations 2003) as concentrated sources of nutrients or other substances with a nutritional or physiological effect, marketed in measured pre-dose forms such as capsules, tablets, pastilles, or ampoules. Under primary food safety legislation—principally the UK Food Safety Act 1990 and assimilated Regulation (EC) No 178/2002 in Great Britain, alongside Regulation (EC) No 178/2002 in the EU—legal liability for product safety rests with the Food Business Operator (FBO) under whose name the product is marketed. Key baseline obligations include: - **General Safety and Traceability:** Ingredients must satisfy food safety criteria, verifying that finished batches are neither injurious to health nor unfit for human consumption, backed by complete one-up, one-down supply chain traceability. - **Quality and Hygiene Controls:** Manufacturing sites must operate documented Hazard Analysis Critical Control Point (HACCP) systems and align with established Good Manufacturing Practice (GMP) principles. - **Contaminant Thresholds:** Finished goods and raw materials must comply with statutory limits for heavy metals (lead, cadmium, and mercury), polycyclic aromatic hydrocarbons (PAHs), ethylene oxide, microbiological criteria, and pesticide residues via validated testing protocols and accredited Certificates of Analysis (CoAs). ## Novel Food Determinations and Technical Dossiers Prior to integrating botanical extracts, isolated bioactives, or synthetic compounds into a formulation, brand owners must confirm an ingredient's regulatory status. Under Regulation (EU) 2015/2283 and its assimilated counterpart in Great Britain, any substance without a demonstrable history of significant consumption in the UK or EU prior to 15 May 1997 is classified as a novel food. Unauthorised novel foods cannot legally be placed on the market. Securing approval requires submitting a comprehensive technical dossier to the relevant authority (the FSA/FSS in the UK or the European Commission/EFSA in the EU). Dossiers must provide detailed compositional characterisation, batch-to-batch consistency, stability data, toxicological evaluations, and proposed usage levels. Formulators should cross-reference both the UK FSA Novel Food Register and the European Commission Novel Food Status Catalogue, as marketing unauthorised ingredients risks trading standards interventions, statutory enforcement notices, and product seizures. ## Permitted Health Claims and Packaging Governance Commercial messaging and label claims are governed by assimilated Regulation (EC) No 1924/2006 in Great Britain and Regulation (EC) No 1924/2006 in the EU. Brand owners may only use health claims authorised on the Great Britain Nutrition and Health Claims (GB NHC) register or the EU Register of Health Claims. Packaging and labelling governance requires adherence to assimilated Regulation (EU) No 1169/2011 and Directive 2002/46/EC, including: - **Prohibition of Medicinal Claims:** Absolute prohibition of claims attributing properties of preventing, treating, or curing human disease, or referencing such properties. - **Wording Fidelity:** Strict conformity with authorised claim wording or permitted adaptations that do not alter the underlying scientific meaning. - **Conditions of Use:** Verification that the recommended daily portion delivers the minimum qualifying quantity of the active compound (typically at least 15% of the Nutrient Reference Value [NRV] for vitamins and minerals). - **Mandatory Pack Elements:** Prominent declaration of directions for use, allergen declarations differentiated through typography (e.g. bold font), a statement indicating that supplements must not be used as a substitute for a varied diet, and an explicit advisory warning not to exceed the recommended daily dose.